IDiyas

For the Inventor, By the Inventor

Voorhees, NJ, United States of America

Benjamin B Mugrage

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 76(Granted Patents)


Location History:

  • Basking Ridge, NJ (US) (1993 - 2006)
  • Voorhees, NJ (US) (2007)
  • Cranberry, NJ (US) (2013)

Company Filing History:

goldMedal10 out of 3,923 
 
Novartis Ag
 patents
silverMedal2 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1993-2013

Loading Chart...
12 patents (USPTO):Explore Patents
1. 8586782 - Phenylacetic acid derivatives (2013-11-19),
2. 8362294 - Phenylacetic acid derivatives (2013-01-29),
3. 7202364 - Certain phenylacetic acids and derivatives (2007-04-10),
4. 7115662 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2006-10-03),
5. 6727281 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2004-04-27),
6. 6451858 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2002-09-17),
7. 6310099 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2001-10-30),
8. 6291523 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2001-09-18),
9. 6174888 - 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones (2001-01-16),
10. 6043365 - Preparation of 2-amino-7-(1-substituted-2-hydroxyethyl)-3, (2000-03-28),
11. 5576439 - Dihydropyridinecarboxylic acid anhydrides (1996-11-19),
12. 5180718 - Acyl derivatives of oxazolorifamycins (1993-01-19),

Title: The Innovative Journey of Benjamin B Mugrage: Pioneering Researcher in Pharmaceuticals

Introduction:

Benjamin B Mugrage, a prominent inventor in the field of pharmaceuticals, has made significant contributions to the treatment of COX-2 dependent disorders. With a keen eye for innovation and a passion for research, Mugrage has left a lasting impact on the industry.

Latest Patents:

Mugrage's latest patents include Phenylacetic acid derivatives - Compounds of formula (I) pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof. These compounds have shown great promise in the treatment of COX-2 dependent disorders, highlighting Mugrage's dedication to advancing healthcare solutions.

Career Highlights:

With an impressive total of 12 patents to his name, Mugrage has worked tirelessly to bring cutting-edge pharmaceutical products to the market. He has been associated with renowned companies such as Novartis AG and Ciba-Geigy Corporation, where his innovative ideas have flourished. Mugrage's relentless pursuit of excellence has earned him a reputation as a trailblazer in the field of pharmaceutical research.

Collaborations:

Throughout his career, Mugrage has collaborated with esteemed professionals in the industry, including Leslie Wighton McQuire and John Henry Van Duzer. These collaborations have led to groundbreaking discoveries and have further solidified Mugrage's position as a pioneer in his field.

Conclusion:

In conclusion, Benjamin B Mugrage's unwavering commitment to innovation and research has significantly impacted the pharmaceutical industry. His patents and collaborations stand as a testament to his dedication to improving healthcare solutions and pushing the boundaries of scientific discovery. Mugrage's legacy as an inventive mind in pharmaceuticals continues to inspire future generations of researchers and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…